Victoria Blinder

Summary

Affiliation: Memorial Sloan-Kettering Cancer Center
Country: USA

Publications

  1. doi request reprint Health disparities and the cancer survivor
    Victoria S Blinder
    Departments of Epidemiology and Biostatistics and of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY Electronic address
    Semin Oncol 40:796-803. 2013
  2. pmc Return to work in low-income Latina and non-Latina white breast cancer survivors: a 3-year longitudinal study
    Victoria S Blinder
    Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Cancer 118:1664-74. 2012
  3. doi request reprint Employment after a breast cancer diagnosis: a qualitative study of ethnically diverse urban women
    V S Blinder
    Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    J Community Health 37:763-72. 2012
  4. doi request reprint Patient perspectives on breast cancer treatment plan and summary documents in community oncology care: a pilot program
    Victoria S Blinder
    Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Cancer 119:164-72. 2013
  5. pmc Early predictors of not returning to work in low-income breast cancer survivors: a 5-year longitudinal study
    Victoria Blinder
    Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA
    Breast Cancer Res Treat 140:407-16. 2013
  6. pmc Cost effectiveness of pharmacogenetic testing for uridine diphosphate glucuronosyltransferase 1A1 before irinotecan administration for metastatic colorectal cancer
    Heather Taffet Gold
    Department of Public Health, Weill Cornell Medical College, New York, NY, USA
    Cancer 115:3858-67. 2009

Detail Information

Publications6

  1. doi request reprint Health disparities and the cancer survivor
    Victoria S Blinder
    Departments of Epidemiology and Biostatistics and of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY Electronic address
    Semin Oncol 40:796-803. 2013
    ..However, the current body of literature is limited in scope and additional research is needed to better define and address disparities among cancer survivors. ..
  2. pmc Return to work in low-income Latina and non-Latina white breast cancer survivors: a 3-year longitudinal study
    Victoria S Blinder
    Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Cancer 118:1664-74. 2012
    ..We set out to compare the trajectories of low-income Latina and non-Latina white survivors and to identify correlates of employment status...
  3. doi request reprint Employment after a breast cancer diagnosis: a qualitative study of ethnically diverse urban women
    V S Blinder
    Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    J Community Health 37:763-72. 2012
    ..These results have important implications for the provision of support services to and clinical management of employed women with breast cancer, as well as for further large-scale research in disparities and employment outcomes...
  4. doi request reprint Patient perspectives on breast cancer treatment plan and summary documents in community oncology care: a pilot program
    Victoria S Blinder
    Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Cancer 119:164-72. 2013
    ..Although the routine use of treatment plans and summaries (TPSs) has been recommended to improve the quality of cancer care, limited data exist about their impact on quality, including patient satisfaction and coordination of care...
  5. pmc Early predictors of not returning to work in low-income breast cancer survivors: a 5-year longitudinal study
    Victoria Blinder
    Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA
    Breast Cancer Res Treat 140:407-16. 2013
    ..Clinicians should discuss work-related concerns with patients and facilitate early return to work when desired by the patient. Additional research is needed to develop interventions to optimize return to work. ..
  6. pmc Cost effectiveness of pharmacogenetic testing for uridine diphosphate glucuronosyltransferase 1A1 before irinotecan administration for metastatic colorectal cancer
    Heather Taffet Gold
    Department of Public Health, Weill Cornell Medical College, New York, NY, USA
    Cancer 115:3858-67. 2009
    ....